olomoucine has been researched along with Carcinoma, Embryonal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldassarre, G; Barone, MV; Belletti, B; Boccia, A; Bruni, P; Fusco, A; Pepe, S; Romano, A; Sandomenico, C; Spiezia, S; Vento, MT; Viglietto, G | 1 |
1 other study(ies) available for olomoucine and Carcinoma, Embryonal
| Article | Year |
|---|---|
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.
Topics: Acetamides; Antigens, Neoplasm; Antigens, Surface; Antigens, Tumor-Associated, Carbohydrate; Apoptosis; Carcinoma, Embryonal; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Differentiation; Cell Survival; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Gene Expression Regulation, Neoplastic; Glycosphingolipids; Humans; Kinetin; Macromolecular Substances; Microtubule-Associated Proteins; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Purines; Retinoblastoma Protein; Roscovitine; Stage-Specific Embryonic Antigens; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1999 |